Biotechnology & Life Sciences Global On demand · 24-48h

Global Single Cell Genomics and Proteomics Market Strategic Research Report

Global Single Cell Genomics and Proteomics Market Strategic …
$3,500 USD
Market Research Reports
Strategic Research Report
Global Single Cell Genomics and Proteomics Market
$2212025
5.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Cell Isolation, Sample Preparation, Genomic Analysis

By Application: Tumor Research, Developmental Biology, Neuroscience, Clinical Diagnostics, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: 10x Genomics, Inc., Standard BioTools Inc, QIAGEN GmbH, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Exact Sciences Corporation, Accelerate Diagnostics, Inc., Bio-Rad Laboratories, Inc., Epic Sciences, Inc., Yikon Genomics Co., Ltd., Takara Bio Inc., 1CellBio, Inc., Bio-Techne Corporation

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 103 pages
Market size 2025
$221
Million USD
Forecast CAGR
5.5%
2025-2032
Forecast 2032
$321.5
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global Single Cell Genomics and Proteomics market size is predicted to grow from US$ 221 million in 2025 to US$ 321 million in 2032; it is expected to grow at a CAGR of 5.5% from 2026 to 2032.

Single-cell genomics and proteomics are cutting-edge technologies for elucidating molecular mechanisms at single-cell resolution. Single-cell genomics amplifies and sequences the entire genome or targeted regions of a single cell, revealing DNA sequence variations, copy number changes, and lineage relationships. It is primarily used to study tumor heterogeneity and mutation accumulation during development. Single-cell proteomics, on the other hand, focuses on identifying and quantifying thousands of proteins within a single cell, directly reflecting the cell's functional state through ultra-sensitive mass spectrometry or novel affinity reagent technologies. The two complement each other: genomics reveals "what might happen," while proteomics reveals "what is happening," jointly advancing the precise understanding of cellular heterogeneity and functional status.

The global development of Single Cell Genomics and Proteomics presents a competitive landscape led by the US and Europe, with the Asia-Pacific region catching up. The US, leveraging its top institutions and instrument companies, dominates single-cell genomics sequencing platforms and high-throughput screening technologies, continuously pushing the limits of throughput and multimodal data fusion. Europe, relying on its strong tradition in proteomics and mass spectrometry, possesses unique advantages in micro-sample preparation, post-translational modification detection, and standardized algorithms for single-cell proteomics. The Asia-Pacific region, with China at its core, focuses on clinical translation and large-scale population cohorts. Through cost-effective domestic platforms and vast sample resources, it is rapidly producing landmark results in tumor heterogeneity and developmental atlases, moving from technology users to rule-makers.

This report presents a comprehensive overview of the global Single Cell Genomics and Proteomics market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Cell Isolation
  • Sample Preparation
  • Genomic Analysis

Segment by Technology

  • Sequencing/Amplification-Based Technology
  • Mass Spectrometry-Based Technology

Segment by Application

  • Genomic Variation
  • Subpopulation Characterization
  • Circulating Tumor Cells
  • Cell Differentiation
  • Others

Segment by Application

  • Tumor Research
  • Developmental Biology
  • Neuroscience
  • Clinical Diagnostics
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Single Cell Genomics and Proteomics market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Tumor Research, Developmental Biology, Neuroscience evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Single Cell Genomics and Proteomics Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$221
2025
Forecast
$321.5
2032
CAGR
5.5%
2025–2032
リージョン
5
global
Key companies
10x Genomics, Inc.Standard BioTools IncQIAGEN GmbHThermo Fisher Scientific Inc.Agilent Technologies, Inc.Exact Sciences CorporationAccelerate Diagnostics, Inc.Bio-Rad Laboratories, Inc.
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Cell IsolationSample PreparationGenomic Analysis
By Application
Tumor ResearchDevelopmental BiologyNeuroscienceClinical DiagnosticsOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Cell Isolation
  • 3.1.3 Sample Preparation
  • 3.1.4 Genomic Analysis
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Tumor Research
  • 4.1.3 Developmental Biology
  • 4.1.4 Neuroscience
  • 4.1.5 Clinical Diagnostics
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 10x Genomics, Inc.
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Standard BioTools Inc
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 QIAGEN GmbH
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Thermo Fisher Scientific Inc.
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Agilent Technologies, Inc.
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Exact Sciences Corporation
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Accelerate Diagnostics, Inc.
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Bio-Rad Laboratories, Inc.
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Epic Sciences, Inc.
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Yikon Genomics Co., Ltd.
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Takara Bio Inc.
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 1CellBio, Inc.
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Bio-Techne Corporation
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Single Cell Genomics and Proteomics market?
The global Single Cell Genomics and Proteomics market is estimated at US$ 221 million in 2025 (base year) and is projected to reach US$ 321 million by 2032.
How fast is the Single Cell Genomics and Proteomics market expected to grow?
The market is expected to grow at a CAGR of 5.5% from 2026 to 2032, expanding from US$ 221 million in 2025 to US$ 321 million in 2032, roughly 1.5 times its base-year value.
What does the Single Cell Genomics and Proteomics market cover?
Single-cell genomics and proteomics are cutting-edge technologies for elucidating molecular mechanisms at single-cell resolution. Single-cell genomics amplifies and sequences the entire genome or targeted regions of a single cell, revealing DNA sequence variations, copy number changes, and lineage relationships. It is primarily used to study tumor heterogeneity and mutation accumulation during development.
How is the Single Cell Genomics and Proteomics market segmented by type?
By type, the market is segmented into Cell Isolation, Sample Preparation and Genomic Analysis.
What are the key applications of Single Cell Genomics and Proteomics?
Key applications covered include Tumor Research, Developmental Biology, Neuroscience, Clinical Diagnostics and Others.
Which companies are profiled in the Single Cell Genomics and Proteomics market report?
Key players profiled include 10x Genomics, Standard BioTools Inc, QIAGEN GmbH, Thermo Fisher Scientific Inc., Agilent Technologies, Exact Sciences Corporation, Accelerate Diagnostics and Bio-Rad Laboratories, among 13 companies covered in total.
What geographies does the Single Cell Genomics and Proteomics market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Single Cell Genomics and Proteomics market report?
The report is intended for manufacturers and solution providers, distributors and end users in Tumor Research, Developmental Biology and Neuroscience, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Single Cell Genomics and Proteomics market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.